Monday, June 25, 2018


This is an important medical advance.  Because of the adequate and well-controlled clinical studies that supported this approval, prescribers can have confidence in the drug's uniform strength and consistent delivery.

-- FDA Commissioner Dr. Scott Gottlieb in a statement accompanying FDA approval of Epidiolex, a treatment for some forms of epilepsy, and the first FDA approved treatment derived from marijuana, CNN, 25 June 2018

No comments: